Table 2.
Correlation of CBX members mRNA expression level with OS and PFS in different pathological grades of ovarian cancer patients
| CBX | Grades | OS | PFS | ||||
|---|---|---|---|---|---|---|---|
| Cases | HR (95% CI) | P value | Cases | HR (95% CI) | P value | ||
| CBX1 | I | 56 | 2.00 (0.77 - 5.21) | 0.1496 | 37 | 3.67 (0.81 - 16.60) | 0.0710 |
| II | 324 | 1.47 (1.05 - 2.05) | 0.0240* | 256 | 1.30 (0.93 - 1.82) | 0.1182 | |
| III | 1015 | 1.41 (1.16 - 1.71) | 0.0004* | 837 | 1.11 (0.94 - 1.31) | 0.2144 | |
| CBX2 | I | 41 | 1.56 (0.43 - 5.64) | 0.4961 | 28 | 2.75 (0.57 - 13.26) | 0.1881 |
| II | 162 | 1.44 (0.92 - 2.24) | 0.1103 | 161 | 1.21 (0.82 - 1.78) | 0.3348 | |
| III | 392 | 1.27 (0.97 - 1.66) | 0.0803 | 315 | 0.79 (0.60 - 1.04) | 0.0896 | |
| CBX3 | I | 56 | 2.34 (0.67 - 8.20) | 0.1711 | 37 | 1.82 (0.60 - 5.59) | 0.2855 |
| II | 324 | 1.38 (1.01 - 1.88) | 0.0434* | 256 | 0.78 (0.56 - 1.10) | 0.1532 | |
| III | 1015 | 1.19 (0.98 - 1.44) | 0.0753 | 837 | 0.86 (0.72 - 1.03) | 0.0983 | |
*P <0.05.